NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$2.01M
Total Shares
223.2K
Net Share Change
+223.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$2.01M223.2K sharesNEW